Cite
HARVARD Citation
Sjöberg, F. et al. (2021). A first‐in‐human oral dose study of mesdopetam (IRL790) to assess its safety, tolerability, and pharmacokinetics in healthy male volunteers. Pharmacology research & perspectives. 9 (3), p. n/a. [Online].